Results help your PlexusDx provider anticipate GERD risk, recommend targeted dietary changes, and select the medication formulation and dose escalation schedule least likely to trigger reflux in your specific genetic profile
The SURMOUNT clinical trials demonstrated that tirzepatide produces weight loss of 15-22% of baseline body weight over 68 weeks, with higher doses generally showing greater effects than lower doses
Data Imputation Methods A number of imputation methods were used across trials to account for missing data, including multiple imputation using retrieved patients, jump to reference multiple imputation, and single imputation as done by Sacks
DSIP DSIP promotes slow-wave delta sleep, the deepest and restorative stage of the sleep cycle
By using a combination of lower doses of both medications, patients might be able to minimize these side effects while still achieving weight loss
Ma K.S.-K., Rezaie A